S Alkanderi1, L M Yates1,2, S A Johnson3, J A Sayer1,4. 1. Newcastle University, Institute of Genetic Medicine, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK. 2. Northern Genetics Service, International Centre for Life, Central Parkway, Newcastle NE1 3BZ, UK. 3. Great North Children's Hospital, Newcastle upon Tyne, NE1 4LP, UK. 4. Renal Services, Newcastle upon Tyne NHS Foundation Trust Hospitals, Newcastle upon Tyne NE7 7DN, UK.
Abstract
BACKGROUND: Inherited renal disorders comprise a significant proportion of cases in both paediatric and adult nephrology services. Genetic advances have advanced rapidly while clinical models of care delivery have remained static. AIM: To describe a cohort of patients attending a multidisciplinary renal genetics clinic and the insights gained from this experience. DESIGN AND METHODS: A retrospective review of clinic cases and their molecular genetic diagnosis over a 5-year period. RESULTS: We report details of 244 individuals including 80 probands who attended the clinic. The commonest reasons for referral was familial haematuria which accounted for 37.5% of cases and cystic kidney disease, accounting for 31% of cases. Eighteen probands had a known molecular genetic diagnosis and were referred for genetic counselling and screening of at risk relatives and management plans. About 62 probands and their families were referred for a precise molecular diagnosis and this was achieved in 26 cases (42%). The most frequent new genetic diagnoses were COL4A5 mutations underlying familial haematuria and familial end stage renal disease. The clinic also allowed for patients with rare renal syndromes to be reviewed, such as ciliopathy syndromes, allowing detailed phenotyping and often a precise molecular genetic diagnosis to be provided. CONCLUSIONS: The integration of modern day genetics and genomics into multidisciplinary clinics often allows a precise diagnosis which benefits patients, their relatives and the clinicians providing care and future management.
BACKGROUND: Inherited renal disorders comprise a significant proportion of cases in both paediatric and adult nephrology services. Genetic advances have advanced rapidly while clinical models of care delivery have remained static. AIM: To describe a cohort of patients attending a multidisciplinary renal genetics clinic and the insights gained from this experience. DESIGN AND METHODS: A retrospective review of clinic cases and their molecular genetic diagnosis over a 5-year period. RESULTS: We report details of 244 individuals including 80 probands who attended the clinic. The commonest reasons for referral was familial haematuria which accounted for 37.5% of cases and cystic kidney disease, accounting for 31% of cases. Eighteen probands had a known molecular genetic diagnosis and were referred for genetic counselling and screening of at risk relatives and management plans. About 62 probands and their families were referred for a precise molecular diagnosis and this was achieved in 26 cases (42%). The most frequent new genetic diagnoses were COL4A5 mutations underlying familial haematuria and familial end stage renal disease. The clinic also allowed for patients with rare renal syndromes to be reviewed, such as ciliopathy syndromes, allowing detailed phenotyping and often a precise molecular genetic diagnosis to be provided. CONCLUSIONS: The integration of modern day genetics and genomics into multidisciplinary clinics often allows a precise diagnosis which benefits patients, their relatives and the clinicians providing care and future management.
Authors: Nasim Bekheirnia; Kevin E Glinton; Linda Rossetti; Joshua Manor; Wuyan Chen; Dolores J Lamb; Michael C Braun; Mir Reza Bekheirnia Journal: Kidney360 Date: 2020-10-30
Authors: Filippo Pinto E Vairo; Carri Prochnow; Jennifer L Kemppainen; Emily C Lisi; Joan M Steyermark; Teresa M Kruisselbrink; Pavel N Pichurin; Rhadika Dhamija; Megan M Hager; Sam Albadri; Lynn D Cornell; Konstantinos N Lazaridis; Eric W Klee; Sarah R Senum; Mireille El Ters; Hatem Amer; Linnea M Baudhuin; Ann M Moyer; Mira T Keddis; Ladan Zand; David J Sas; Stephen B Erickson; Fernando C Fervenza; John C Lieske; Peter C Harris; Marie C Hogan Journal: Kidney Med Date: 2021-06-29
Authors: Mark D Elliott; Leslie C James; Emily L Simms; Priyana Sharma; Louis P Girard; Kim Cheema; Meghan J Elliott; Julie L Lauzon; Justin Chun Journal: Can J Kidney Health Dis Date: 2021-10-29
Authors: Andrew J Mallett; Catherine Quinlan; Chirag Patel; Lindsay Fowles; Joanna Crawford; Michael Gattas; Richard Baer; Bruce Bennetts; Gladys Ho; Katherine Holman; Cas Simons Journal: Kidney Med Date: 2019-08-14
Authors: Andrew J Mallett; Catherine Quinlan; Kushani Jayasinghe; Zornitza Stark; Peter G Kerr; Clara Gaff; Melissa Martyn; John Whitlam; Belinda Creighton; Elizabeth Donaldson; Matthew Hunter; Anna Jarmolowicz; Lilian Johnstone; Emma Krzesinski; Sebastian Lunke; Elly Lynch; Kathleen Nicholls; Chirag Patel; Yael Prawer; Jessica Ryan; Emily J See; Andrew Talbot; Alison Trainer; Rigan Tytherleigh; Giulia Valente; Mathew Wallis; Louise Wardrop; Kirsty H West; Susan M White; Ella Wilkins Journal: Genet Med Date: 2020-09-17 Impact factor: 8.822
Authors: Christie P Thomas; Margaret E Freese; Agnes Ounda; Jennifer G Jetton; Myrl Holida; Lama Noureddine; Richard J Smith Journal: Genet Med Date: 2020-03-17 Impact factor: 8.822